Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Noble Romans (NROM) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Noble Romans (NROM) over the last 15 years, with Q3 2025 value amounting to 19.77%.

  • Noble Romans' EBIT Margin rose 90300.0% to 19.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.68%, marking a year-over-year increase of 4600.0%. This contributed to the annual value of 9.74% for FY2024, which is 141900.0% down from last year.
  • Per Noble Romans' latest filing, its EBIT Margin stood at 19.77% for Q3 2025, which was up 90300.0% from 22.4% recorded in Q2 2025.
  • In the past 5 years, Noble Romans' EBIT Margin registered a high of 35405.24% during Q1 2021, and its lowest value of 11.86% during Q4 2022.
  • Its 5-year average for EBIT Margin is 2902.27%, with a median of 13.74% in 2023.
  • Its EBIT Margin has fluctuated over the past 5 years, first surged by 353835800bps in 2021, then tumbled by -354006500bps in 2022.
  • Quarter analysis of 5 years shows Noble Romans' EBIT Margin stood at 2.95% in 2021, then crashed by -302bps to 11.86% in 2022, then surged by 276bps to 20.87% in 2023, then plummeted by -91bps to 1.85% in 2024, then soared by 971bps to 19.77% in 2025.
  • Its EBIT Margin stands at 19.77% for Q3 2025, versus 22.4% for Q2 2025 and 13.34% for Q1 2025.